Prevalence of HPV After Introduction of the Vaccination Program in the United States
This article, published in Pediatrics, reports the results of a study that examined the prevalence of human papillomavirus (HPV) before and after the introduction of HPV vaccines in the United States. The authors found that there was a 64 percent decrease in prevalence of HPV types covered in the quadrivalent vaccine among females aged 14 to 19 years of age and a 34 percent decrease among those aged 20 to 24 years. These findings extend previous observations of population impact in the United States and demonstrate the first national evidence of impact among females in their 20s.
Author: Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER
» Visit web page (English)
(Located at pediatrics.aappublications.org)
Citation: Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV After Introduction of the Vaccination Program in the United States. Pediatrics. 2016;137(3):1-9.
Resource types: Peer-reviewed journal
Diseases/vaccines: Human papillomavirus (HPV)
Regions: North America and Europe